JSP191-Based Conditioning
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation With JSP191-Based Conditioning in Participants With GATA2 Deficiency
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 40 patients (estimated)
- Sponsors
- National Cancer Institute (NCI)
- Tags
- Allogeneic Stem Cell Transplant, Monoclonal Antibody
- Trial Type
- Treatment
- Last Update
- 1 week ago
- SparkCures ID
- 1734
- NCT Identifier
- NCT05907746
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.